Cargando…
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
SIMPLE SUMMARY: RAS mutation is the most frequent oncogenic alteration in human cancers and KRAS is the most frequently mutated, notably in non-small cell lung carcinomas (NSCLC). Various attempts to inhibit KRAS in the past were unsuccessful in these latter tumors. However, recently, several small...
Autores principales: | Bontoux, Christophe, Hofman, Véronique, Brest, Patrick, Ilié, Marius, Mograbi, Baharia, Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996900/ https://www.ncbi.nlm.nih.gov/pubmed/35406400 http://dx.doi.org/10.3390/cancers14071628 |
Ejemplares similares
-
More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021) -
Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021) -
COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021) -
Host Polymorphisms May Impact SARS-CoV-2 Infectivity
por: Brest, Patrick, et al.
Publicado: (2020) -
Host genetic variability and determinants of severe COVID-19
por: Brest, Patrick, et al.
Publicado: (2023)